Hospira Announces Plans to Integrate Symbiq(R) and EndoTool(R) Technologies





Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today announced the coming integration of its clinician-friendly Symbiq(R) smart infusion pump and industry-leading EndoTool(R) glucose management software. 

Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today announced the coming integration of its clinician-friendly Symbiq(R) smart infusion pump and industry-leading EndoTool(R) glucose management software.

Philip Settimi, M.D., vice president, Global Marketing, Global Devices, Hospira said, Unveiling the integrated Symbiq and EndoTool development effort illustrates Hospira's commitment to providing cutting-edge medication delivery technology, and ensuring compatibility between and integration of important hospital technologies.

The Symbiq infusion system is a highly advanced, easy-to-use device with several clinician-friendly features to help improve workflow and decrease medication errors. An estimated 1.5 million medication errors occur annually, with 400,000 preventable drug-related injuries occurring in hospitals (1). With Hospira MedNet(R) safety software built into the device, Symbiq was the first general infusion system designed to provide additional medication-error protection by ensuring compliance with safety software. Symbiq requires users to select a drug library entry from the safety software for all drug delivery programs. With its innovative, award-winning human factors design, Symbiq also incorporates an intuitive layout and a large LCD touch screen to help minimize pump programming errors.